Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151 USD | -2.38% | +6.75% | +53.01% |
12:38pm | Jefferies Adjusts Price Target on Moderna to $180 From $155, Keeps Buy Rating | MT |
11:50am | Moderna: experimental treatment selected by the FDA | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.01% | 59.28B | |
+41.65% | 40.94B | |
-6.21% | 40.17B | |
-5.56% | 28.69B | |
+10.91% | 26.63B | |
-22.92% | 18.89B | |
+30.43% | 12.46B | |
+1.06% | 12.42B | |
+26.25% | 12.26B | |
-8.30% | 11.42B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech